Lexology October 28, 2024
Covington advised AbbVie in its definitive agreement to acquire Aliada Therapeutics, a biotechnology company advancing therapies using a novel blood-brain barrier (BBB)-crossing technology to address challenging central nervous system (CNS) diseases. Under the terms of the agreement, AbbVie will acquire all outstanding...